Spineart
Private Company
Funding information not available
Overview
Spineart is a fast-growing, privately-held global spine surgery company headquartered in Geneva, Switzerland. It leverages a comprehensive portfolio of 28 product families across motion preservation, fixation, and fusion, supported by enabling technologies like 3D-printed implants and robotic guidance. With over 370 employees, the company completed more than 50,000 surgeries in 2024 and positions itself among the top ten spine companies worldwide, targeting a global market exceeding $12 billion.
Technology Platform
Portfolio of spinal implants (motion preservation, fixation, fusion) integrated with enabling technologies including 3D-printed implants and partnerships in robotic surgical guidance/navigation.
Opportunities
Risk Factors
Competitive Landscape
Spineart operates in the highly competitive global spine device market, competing directly with large public companies like Medtronic, Stryker, Johnson & Johnson (DePuy Synthes), and NuVasive. Its differentiation is based on a surgeon-centric design philosophy, a focus on procedural simplicity, and a strategy of open collaboration in the robotics space rather than a closed, proprietary ecosystem.